The human IL-15 superagonist complex ALT-803 drives SIV-specific CD8+ T cells into B cell follicles

• G. Webb,
• S. Li,
• G. Mwakalundwa,
• J.S. Reed,
• J.J. Stanton,
• A.W. Legasse,
• J. Folkvord,
• B.S. Park,
• M.K. Axthelm,
• E.K. Jeng,
• H.C. Wong,
• J.B. Whitney,
• R. Brad Jones,
• D.F. Nixon,
• E. Connick,
• P.J. Skinner,
• J.B. Sacha

Affiliations

G. Webb

Oregon Health and Science University, Beaverton, USA

S. Li

University of Minnesota, Minneapolis, MN, USA

G. Mwakalundwa

University of Minnesota, Minneapolis, MN, USA

J.S. Reed

Oregon Health and Science University, Beaverton, USA

J.J. Stanton

Oregon Health and Science University, Beaverton, USA

A.W. Legasse

Oregon Health and Science University, Beaverton, USA

J. Folkvord

University of Arizona, Tucson, AZ, USA

B.S. Park

Oregon Health and Science University, Beaverton, USA

M.K. Axthelm

Oregon Health and Science University, Beaverton, USA

E.K. Jeng

Altor Bioscience Corporation, Miramar, FL, USA

H.C. Wong

Altor Bioscience Corporation, Miramar, FL, USA

J.B. Whitney

Ragon Institute, Harvard Medical School, Cambridge, MA, USA

R. Brad Jones

George Washington University, Washington DC, USA

D.F. Nixon

George Washington University, Washington DC, USA

E. Connick

University of Arizona, Tucson, AZ, USA

P.J. Skinner

University of Minnesota, Minneapolis, MN, USA

J.B. Sacha

Oregon Health and Science University, Beaverton, USA